These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37056933)

  • 1. Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m
    Chen M; Zhang Q; Zheng S; Guo X; Cao L; Ren Y; Qian Y; Wang M; Wu X; Xu K
    Int J Biol Sci; 2023; 19(5):1616-1632. PubMed ID: 37056933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
    Fan Y; Yu Y
    Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m
    Li Y; Li X; Deng M; Ye C; Peng Y; Lu Y
    Oxid Med Cell Longev; 2022; 2022():4320809. PubMed ID: 36246404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway.
    Xu L; Li K; Li J; Xu F; Liang S; Kong Y; Chen B
    Epigenetics; 2023 Dec; 18(1):2265625. PubMed ID: 37871286
    [No Abstract]   [Full Text] [Related]  

  • 5. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
    Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
    Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification.
    Ren H; Wang M; Ma X; An L; Guo Y; Ma H
    Biol Direct; 2024 Aug; 19(1):68. PubMed ID: 39160584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y; Liu S; Zhao T; Dang C
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Fibroblasts Promote Migration and Invasion of Non-Small Cell Lung Cancer Cells
    Guo X; Chen M; Cao L; Hu Y; Li X; Zhang Q; Ren Y; Wu X; Meng Z; Xu K
    Front Cell Dev Biol; 2021; 9():764151. PubMed ID: 34977016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer.
    Xu X; Zhang P; Huang Y; Shi W; Mao J; Ma N; Kong L; Guo L; Liu J; Chen J; Lu R
    Cancer Sci; 2023 Jan; 114(1):105-114. PubMed ID: 36114749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 suppresses invasion of lung cancer via SH3BP5 m6A modification.
    Zhang B; Qian R; Li X
    Arch Biochem Biophys; 2024 Feb; 752():109876. PubMed ID: 38141906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.
    He G; Gu K; Wei J; Zhang J
    Thorac Cancer; 2024 Apr; 15(11):919-928. PubMed ID: 38462740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.
    Chen H; Zhao L; Meng Y; Qian X; Fan Y; Zhang Q; Wang C; Lin F; Chen B; Xu L; Huang W; Chen J; Wang X
    Cancer Lett; 2022 Jun; 536():215611. PubMed ID: 35240233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
    Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
    Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.
    Cao Y; Di X; Cong S; Tian C; Wang Y; Jin X; Zhao M; Zhou X; Li R; Wang K
    Life Sci; 2023 Feb; 315():121359. PubMed ID: 36608868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.